Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Prime Medicine (PRME) Assets Average (2022 - 2025)

Historic Assets Average for Prime Medicine (PRME) over the last 4 years, with Q3 2025 value amounting to $332.0 million.

  • Prime Medicine's Assets Average rose 1207.31% to $332.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $332.0 million, marking a year-over-year increase of 1207.31%. This contributed to the annual value of $245.7 million for FY2024, which is 1133.34% down from last year.
  • Per Prime Medicine's latest filing, its Assets Average stood at $332.0 million for Q3 2025, which was up 1207.31% from $303.6 million recorded in Q2 2025.
  • Over the past 5 years, Prime Medicine's Assets Average peaked at $338.6 million during Q1 2023, and registered a low of $216.5 million during Q4 2023.
  • In the last 4 years, Prime Medicine's Assets Average had a median value of $297.6 million in 2023 and averaged $291.7 million.
  • Data for Prime Medicine's Assets Average shows a peak YoY increase of 4556.53% (in 2024) and a maximum YoY decrease of 2540.03% (in 2024) over the last 5 years.
  • Quarter analysis of 4 years shows Prime Medicine's Assets Average stood at $287.8 million in 2022, then fell by 24.77% to $216.5 million in 2023, then soared by 45.57% to $315.1 million in 2024, then grew by 5.35% to $332.0 million in 2025.
  • Its Assets Average was $332.0 million in Q3 2025, compared to $303.6 million in Q2 2025 and $312.8 million in Q1 2025.